SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 39.47 |
| Enterprise Value ($M) | -13.42 |
| Book Value ($M) | 46.12 |
| Book Value / Share | 0.83 |
| Price / Book | 0.86 |
| NCAV ($M) | -11.53 |
| NCAV / Share | -0.21 |
| Price / NCAV | -3.42 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.36 |
| Return on Assets (ROA) | -0.41 |
| Return on Equity (ROE) | -0.71 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.08 |
| Current Ratio | 1.08 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 52.89 |
| Assets | 110.54 |
| Liabilities | 64.42 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 47.98 |
| Operating Income | -72.48 |
| Net Income | -68.57 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -23.44 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Glaxosmithkline Plc | 16.40 | 0.00 | |
| 13G/A | Anson Funds Management LP | 6.90 | -12.73 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 152,570 | 328,420 | 46.46 | |
| 12,149 | 56,528 | 21.49 | |
| 22,036 | 176,759 | 12.47 | |
| 21,605 | 174,086 | 12.41 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| SLDB – Solid Biosciences Inc. | SLRN – Acelyrin, Inc. |
| SNDX – Syndax Pharmaceuticals, Inc. | SRPT – Sarepta Therapeutics, Inc. |
| SRRK – Scholar Rock Holding Corporation |
Financial data and stock pages provided by
Fintel.io